Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people taking Wegovy notice some weight change within the first four to eight weeks, though meaningful, sustained loss typically builds over several months as the dose increases. Clinical trial data show an average reduction of around 15% of body weight over 68 weeks at the 2.4mg maintenance dose — a result that arrives gradually, not overnight. Wegovy is a prescription-only medicine; a qualified prescriber assesses whether it's clinically appropriate for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy starts at 0.25mg, a dose chosen specifically to let your body adjust to the medicine rather than to drive immediate weight loss. That can feel frustrating when you're eager to see results. The honest truth is that the early weeks are largely about tolerability: your digestive system is adapting, your appetite signals are beginning to shift, and the groundwork is being laid for what comes next.
Some people do notice they feel fuller sooner at meals during this period, and a modest reduction in portion size can follow naturally. On the scales, however, most people see little change in the first four weeks, which is exactly what the evidence on how soon you see weight loss with Wegovy would lead you to expect. The NHS patient information for semaglutide explains that treatment is a stepped process, and the starter dose is not the therapeutic one.
Practically, this is also the stage when side effects (mainly nausea, sometimes loose stools or indigestion) are most noticeable. They tend to settle within a few weeks for most people, particularly if meals are smaller and lower in fat.
Each four-weekly step up through 0.5mg, 1.0mg and then 1.7mg brings a stronger appetite-reducing effect, and this is when the scales typically start moving more consistently. Research published in the STEP 1 trial in the New England Journal of Medicine showed that weight loss accumulated progressively across the treatment period, it was not front-loaded.
By the end of month three, many participants in clinical trials had lost somewhere between 5% and 8% of their starting weight. By month six, losses approaching 10% were common among those who reached or were near the maintenance dose. These are averages; individual results vary depending on starting weight, diet, activity and how the dose is tolerated.
This phase is also where lifestyle changes begin to compound the medicine's effect. Wegovy reduces appetite; what you do with that reduced appetite (prioritising protein, staying hydrated, building in movement) shapes how those months land. For a broader look at how long Wegovy takes to produce its full effect, the timeframes are longer than many people expect at the outset.
Once the 2.4mg maintenance dose is reached and tolerated, weight loss continues but the rate often begins to plateau as the body finds a new equilibrium. If you're curious how quickly Wegovy works for weight loss across the full treatment arc, the STEP 1 trial's 68-week endpoint (around 15% average body-weight reduction) reflects this journey from start to stable maintenance. For context, that's roughly 15kg for someone starting at 100kg.
The NICE technology appraisal for semaglutide (TA875) recommends that treatment be reviewed if less than 5% of body weight has been lost after six months at the maintenance dose. If weight loss is on track, NICE guidance supports continuing for up to two years within a specialist weight management service on the NHS.
For those prescribed Wegovy privately (the route available through a service like ours) the same clinical logic applies: a prescriber reviews progress before each repeat, and the medicine's role is to support, not replace, dietary and activity changes. You can read about the pace of weight loss on Wegovy in more detail, including what factors tend to influence individual results.
The MHRA approved a higher 7.2mg maintenance dose in January 2026, with trial data showing average reductions of around 20.7% over 72 weeks, approaching what the tirzepatide trials reported. That dose follows the same stepped titration from 0.25mg; it does not deliver faster early results, only a higher ceiling over time.
Comparing your progress to headline trial figures can be discouraging, because those figures are averages across hundreds of participants with different starting points. Slower early loss does not mean the medicine isn't working, and understanding how quick weight loss with Wegovy typically is can help set more realistic expectations from the start.
A few things genuinely affect the pace: how consistently the injection is taken each week, whether the dose has been increased on schedule, alcohol intake (calorically dense and often overlooked), sleep quality, and whether protein and fibre are adequate given the reduced appetite. Skipping doses can blunt the cumulative effect.
If you're considering what treatment might suit you or want to understand the range of weight-loss treatment options available, reading around the subject first is a reasonable starting point. For questions specific to your situation (dose timing, what to do after a missed injection, whether your progress is on track) those conversations belong with your prescriber, not a forum. If you're wondering how quickly you see results with Wegovy, our frequently asked questions cover some of the most common practical queries.
Wegovy is dispensed at nume as a prescription-only medicine, reviewed personally by a GPhC-registered prescriber before every order. If you'd like to explore whether you're eligible, you can check your eligibility through a free consultation, no commitment, reviewed the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.